The pros and cons of buying Challenger shares this month

Could this be the right time to look at the annuity king?

| More on:
Two people comparing and analysing material.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Challenger Ltd (ASX: CGF) share price jumped 6.5% yesterday after reporting its FY24 result. Investors loved the ASX financial share's report which showed good growth. After such good numbers, it's worth asking if the annuity provider is a buy.

A business can still be good value even if it goes up in price because the reported numbers may have demonstrated that the current share price still doesn't reflect how good the outlook truly is.

The business reported a number of positives, which may bode well for FY25 (and beyond).

Let's run through some of the highlights before considering if it's a buy.

Positive result recap

The company reported that it generated normalised net profit before tax (NPBT) of $608 million, up 17%.

Challenger's group assets under management (AUM) grew by 21% to $127 billion, partly thanks to life sales of $9.1 billion, with lifetime annuity sales of $1.5 billion (up 110%).

Normalised earnings per share (EPS) grew by 14% to 60.9 cents per share. The normalised return on equity (ROE) was 15.6%, up 290 basis points (2.90%) – Challenger said it's on track to achieve its ROE target in FY25. The ROE target is the RBA cash rate plus a margin of 12%.

The board of Challenger decided to lift the full-year dividend by 10% to 26.5 cents per share.

However, the company did report that its statutory net profit after tax (NPAT) declined 24% to $130 million. This number included the unrealised impact of lower commercial property valuations and changes to the UK mortality rate assumptions.

The broker UBS said that earnings beat market expectations and were ahead of the guidance range, and the dividend was stronger than expected, which helped the Challenger share price rise. However, the statutory net profit was "surprisingly low due to very large investment experience loss". Despite that, the balance sheet strength improved.

UBS suggested there were some question marks on the company's capital position.  

Is the Challenger share price a buy?

The outlook for the business seems positive, in my opinion, though I'm wary that eventual lowering interest rates may make annuities seem a little less appealing to retirees if they lead to lower payment rates.

The broker believes the FY24 result "went a long way to addressing market concerns for life margins, capital and business quality". Cost control was a "key feature", and it sees "further earnings upside from this source".

UBS suggested that Challenger's guidance appears to be conservative, with the broker forecasting a net profit before tax of $695 million. Challenger's guidance for normalised NPBT is between $640 million and $700 million.

The broker rates Challenger shares as a buy and increased its price target to $8.30. That implies a possible rise of around 13% from today's level.

Challenger is guiding normalised net profit after tax will be between $440 million to $480 million. UBS is forecasting NPAT of $487 million in FY25 and $561 million in FY26.

The broker is also suggesting the annual dividend per share could rise to 31 cents per share in FY25 and 35 cents per share in FY26. The FY25 dividend could translate into a grossed-up dividend yield of around 6%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Challenger. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Financial Shares

Man with rocket wings which have flames coming out of them.
Financial Shares

Up more than 900% in 5 years, can this ASX All Ords financials stock go higher?

The share price of this company has left others behind in the dust.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Financial Shares

HMC Capital shares are down 50% in 2025, can they turn around?

HMC Capital shares have plunged more than 50% this year, but with solid investments in energy, private credit, and data…

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Financial Shares

Forget the Big 4 banks and buy these 2 compelling ASX 200 financials stocks

The Big 4 banks might be steady, but if you’re after real growth in financials, here are two modern, scalable…

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Buy this surging ASX 300 stock before the next interest rate cut

A leading fund manager expects more upside from this surging ASX 300 stock.

Read more »

woman talking on the phone and giving financial advice whilst analysing the stock market on the computer with a pen
Financial Shares

Why this ASX All Ords stock surged yesterday

Investors sent this ASX All Ords stock flying higher. But why?

Read more »

Young woman thinking with laptop open.
Financial Shares

Does Macquarie tip more upside for Suncorp or IAG shares?

Macquarie analysed the outlook for both Suncorp and IAG shares in the year ahead.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Why this $2 billion ASX 200 stock looks undervalued today

A leading expert believes this ASX 200 company is poised to ‘unlock some decent value’.

Read more »

A woman smiles at the outlook she sees through binoculars.
Financial Shares

Here's the earnings forecast out to 2030 for Macquarie shares

What’s expected of investment bank Macquarie?

Read more »